Quick Overview
KLOW is a multi-peptide investigational complex designed to integrate angiogenesis, extracellular matrix remodelling, cellular migration, and inflammatory modulation pathways within a single research framework.

Full Research Overview
KLOW represents a composite formulation combining four peptides with complementary biological roles: BPC-157, TB-500 (thymosin beta-4 fragment), GHK-Cu, and KPV.
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from gastric proteins. It has been studied for its role in angiogenesis, vascular integrity, and tissue repair signalling pathways, particularly involving nitric oxide modulation and endothelial function.




